Friday, June 21, 2024

NIH LIED About Dangerous Gain-Of-Function Virus Research, Withheld Information From Congress

 On June 11, House investigators on the Energy and Commerce Committee released a 73-page report exposing that National Institutes of Health officials lied about gain-of-function virus research to reporters and withheld information from Congress.

The first variant was clade 2, which until recently was found only in West Africa and is now causing the global outbreak and the other one is clade 1, which is believed to be much deadlier and caused outbreaks in the Democratic Republic of Congo for decades.

According to Science, Moss found that clade 1 virus can kill a mouse at levels 1000 times lower than those needed with clade 2.

Now, they are planning to try the opposite, endowing the clade 2 virus with genes from its deadlier relative.

NIAID said that Kaiser later updated her article to claim that Moss' research would only involve clade 2a and not clade 2b monkeypox virus.

House investigators found that weeks after NIAID claimed to Kaiser that Moss' planned monkeypox research involved clade 2a, not clade 2b monkeypox, Moss posted a preprint reporting he already started research with clade 2a and planned research with clade 2b. "We have started to investigate the genetic determinants responsible for virulence differences of clade I and IIa viruses and plan to extend this to clade IIb pending institutional approval," Moss and co-authors wrote in a preprint.

After investigators threatened a subpoena, NIH relented and admitted in March that Moss had submitted a formal proposal to insert genes from the more deadly clade 1 monkeypox strain into the more common and transmissible clade 2 monkeypox virus.

Investigators have not demanded that NIH explain who provided false information to Branswell claiming Moss had not proposed the monkeypox research he had actually proposed and was approved to conduct in 2015. 

https://www.naturalnews.com/2024-06-20-nih-lied-about-gain-of-function-research.html

No comments:

Post a Comment